Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 14 Best S&P 500 Stocks to Buy Now. As of the close of business on December 17, Wall Street analysts have a consensus Strong Buy rating on the stock, with a one-year average share price target of $640.30, representing an upside of 12%.
Recent analyst updates include Wells Fargo lifting its price target on the stock to $675 from $635 on December 15, citing increased clarity about the U.S. government’s policies on the pharmaceutical industry, coupled with future growth projections suggesting an upside.
The firm believes the situation is ripe for companies selling tools and equipment, and has kept its Overweight rating on the stock.
This followed Citigroup’s update on Thermo Fisher Scientific Inc. (NYSE:TMO) on December 11, when it upgraded the stock’s rating to Buy from Neutral and hiked its price target to $660 from $580.
The revision by Citi analyst Patrick Donnelly was part of the firm’s broader analysis for stocks in the tools and diagnostics segment heading into 2026. The firm believes ongoing onshoring trends and increased pharmaceutical spending will benefit the company.
Thermo Fisher Scientific Inc. (NYSE:TMO) is a leading provider of life sciences solutions, laboratory products, diagnostics, analytical instruments, and biopharma services. The stock has had modest returns in 2025, gaining 8% year-to-date.
While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 11 Most Oversold S&P 500 Stocks Heading into 2026 and Top 15 Lowest P/E Ratios of the S&P 500 in 2025.
Disclosure: None.